0001225208-17-001645.txt : 20170125
0001225208-17-001645.hdr.sgml : 20170125
20170125172930
ACCESSION NUMBER: 0001225208-17-001645
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20170123
FILED AS OF DATE: 20170125
DATE AS OF CHANGE: 20170125
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BB&T CORP
CENTRAL INDEX KEY: 0000092230
STANDARD INDUSTRIAL CLASSIFICATION: NATIONAL COMMERCIAL BANKS [6021]
IRS NUMBER: 560939887
STATE OF INCORPORATION: NC
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 200 WEST SECOND STREET
CITY: WINSTON-SALEM
STATE: NC
ZIP: 27101
BUSINESS PHONE: 3367332000
MAIL ADDRESS:
STREET 1: 200 WEST SECOND STREET
CITY: WINSTON-SALEM
STATE: NC
ZIP: 27101
FORMER COMPANY:
FORMER CONFORMED NAME: SOUTHERN NATIONAL CORP /NC/
DATE OF NAME CHANGE: 19920703
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DUCK BARBARA F
CENTRAL INDEX KEY: 0001260887
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-10853
FILM NUMBER: 17547364
MAIL ADDRESS:
STREET 1: C/O BB&T
STREET 2: P O BOX 1250
CITY: WINSTON SALEM
STATE: NC
ZIP: 27102-1250
4
1
doc4.xml
X0306
4
2017-01-23
0000092230
BB&T CORP
BBT
0001260887
DUCK BARBARA F
PO BOX 1250
WINSTON-SALEM
NC
27102-1250
1
Sr. Executive Vice President
Common Stock
2017-01-23
4
M
0
54138.0000
34.2900
A
137152.0000
D
Common Stock
2017-01-23
4
M
0
41077.0000
44.1500
A
178229.0000
D
Common Stock
2017-01-23
4
M
0
36875.0000
27.7500
A
215104.0000
D
Common Stock
2017-01-23
4
M
0
28505.0000
27.7300
A
243609.0000
D
Common Stock
2017-01-23
4
S
0
160595.0000
45.2779
D
83014.0000
D
Common Stock
18042.7380
I
By 401(k)
Common Stock
3612.3300
I
By IRA
Stock Option (right to buy)
44.1500
2017-01-23
4
M
0
41077.0000
0.0000
D
2008-02-20
2017-02-20
Common Stock
41077.0000
0.0000
D
Stock Option (right to buy)
27.7300
2017-01-23
4
M
0
28505.0000
0.0000
D
2012-02-22
2021-02-22
Common Stock
28505.0000
0.0000
D
Stock Option (right to buy)
27.7500
2017-01-23
4
M
0
36875.0000
0.0000
D
2011-02-23
2020-02-23
Common Stock
36875.0000
0.0000
D
Stock Option (right to buy)
34.2900
2017-01-23
4
M
0
54138.0000
0.0000
D
2009-02-26
2018-02-26
Common Stock
54138.0000
0.0000
D
Stock Option (right to buy)
30.0800
2014-02-26
2023-02-26
Common Stock
21587.0000
21587.0000
D
Stock Option (right to buy)
30.0900
2013-02-21
2022-02-21
Common Stock
36455.0000
36455.0000
D
Stock Option (right to buy)
37.5500
2015-02-25
2024-02-25
Common Stock
10263.0000
10263.0000
D
Stock Option (right to buy)
38.2200
2016-03-15
2025-02-24
Common Stock
8833.0000
8833.0000
D
The price in Column 4 is a weighted average price. The prices actually received ranged from $45.2600 to $45.3200. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
Includes 248.106 shares acquired between July 1, 2016 and December 31, 2016, under the Issuer's 401(k) plan. The information in this report is based on plan statements dated July 1, 2016 through December 31, 2016.
Includes 51.422 shares acquired in September 2016 and December 2016, under the Dividend Reinvestment Plan.
The option is exercisable in five equal annual installments beginning on 2/20/2008.
The option is exercisable in four equal annual installments beginning on 2/22/2012.
The option is exercisable in four equal annual installments beginning on 02/23/2011.
The option is exercisable in five equal annual installments beginning on 2/26/2009.
The option is exercisable in three equal annual installments beginning on 02/26/2014.
The option is exercisable in four equal annual installments beginning on 02/21/2013.
On February 25, 2014, the reporting person was granted an option to purchase 15,396 shares of common stock. The option vests ratably over three years based on certain performance criteria for each vesting year ending February 25, 2015, 2016, and 2017. The performance criteria for 2016 were met, resulting in vesting of the option as to 5,132 shares.
On February 24, 2015, the reporting person was granted an option to purchase 26,500 shares of common stock. The option vests ratably over three years based on certain performance criteria for each vesting year March 15, 2016, 2017, and 2018. The performance criteria for 2016 were met, resulting in vesting of the option as to 8,833 shares.
poa.txt
Carla Brenwald, Attorney-in-fact
2017-01-25
EX-24
2
poa.txt
POWER OF ATTORNEY
The undersigned, being a director and/or officer of BB&T Corporation
("Company"), hereby nominates, constitutes, and appoints Alan W. Greer, Tamera
Gjesdal, Carla Brenwald, Sallie Stone, Robert J. Johnson, Jr., Sean P. Kehoe and
Bradley T. Kamlet, or any one of them severally and with full power of
substitution, to be his or her true and lawful attorney-in-fact in connection
with any Securities and Exchange Commission ("Commission") filings on behalf of
the undersigned pursuant to Section 16 of the Securities Exchange Act of 1934,
as amended, as may arise out of the undersigned's ownership of the Company's
securities. Accordingly, any such attorney-in-fact is authorized to complete
and execute for and on behalf of the undersigned, in the undersigned's capacity
as an officer or director or both of the Company, any such filings and to take
any other action in connection with the foregoing which, in the opinion of such
attorney-in-fact, may be of benefit to, in the best interest of, or legally
required by or for, the undersigned. Without limiting the generality of the
foregoing, any such attorney-in-fact is authorized to file with the Commission
the Initial Statement of Beneficial Ownership of Securities on Form 3, the
Statement of Changes in Beneficial Ownership of Securities on Form 4, the Annual
Statement of Changes in Beneficial Ownership of Securities on Form 5, and any
other statements, reports or filings, making such changes in and amendments to
said reports and filings as such attorney-in-fact deems appropriate. Any such
attorney-in-fact is futher authorized to seek or obtain, as the undersigned's
representative and on the undersigned's behalf, information on transactions in
the Company's securities from any third party, including brokers, employee
benefit plan administrators and trustees.
This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 3, 4, and 5 with respect to the
undersigned's holdings of and transaction in securities issued by the Company,
unless earlier revoked by the undersigned in a signed writing delivered to the
foregoing attorneys-in-fact.
IN WITNESS WHEREOF, I hereby sign and seal this Power of Attorney this 10th day
of August, 2016.
/s/ Barbara F. Duck
Barbara F. Duck